Study gives insights into quality of life for adults with congenital heart disease

Washington : Adults with congenital heart disease (CHD) can now gain vital insights into their long-term quality of life according to data from the Congenital Heart Initiative (CHI). CHI is the nation’s first and largest patient-focused registry for people with CHD, and it recently launched its inaugural research, which included over 4,500 participants from all…

Read More

Diet has significant impact on risk of Alzheimer’s disease: Research

California : In a detailed study, researchers identify which diets are effective in lowering the risk of developing Alzheimer’s disease. Findings were published in the Journal of Alzheimer’s Disease, Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding. The role of nutrition in lowering the risk of Alzheimer’s disease has been extensively…

Read More

Hasty conclusion: Kumari Selja on early trends showing BJP’s lead over Cong in Haryana

New Delhi- Senior Congress leader Kumari Selja on Tuesday said that drawing conclusions based on trends so early in the day is “hasty” and expressed strong confidence in Congress winning the Haryana Assembly elections. “Congress is winning. One should not draw conclusions so early. Counting is still underway. One should not be hasty,” Selja told…

Read More

JP Nadda announces implementation of 100 Days Initiatives by Dept of Health Research

New Delhi : Union Health Minister JP Nadda has announced the successful implementation of 100 Days Program of the Union Health Ministry’s Department of Health Research (DHR). He said “these initiatives represent transformative steps in healthcare innovation, pandemic preparedness, and the development of indigenous medical solutions, contributing to a healthier, more resilient and Atmanirbhar Bharat.”…

Read More

Long-term metastatic melanoma survival dramatically improves on immunotherapy: Study

New York: Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre investigators and colleagues. The 10-year follow-up research, published in…

Read More